Product NDC: | 60575-313 |
Proprietary Name: | Tricode |
Non Proprietary Name: | Chlorpheniramine Maleate, Codeine Phosphate, Pseudoephedrine Hydrochloride |
Active Ingredient(s): | 2; 8; 30 mg/5mL; mg/5mL; mg/5mL & nbsp; Chlorpheniramine Maleate, Codeine Phosphate, Pseudoephedrine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60575-313 |
Labeler Name: | Respa Pharmaceuticals, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20110620 |
Package NDC: | 60575-313-16 |
Package Description: | 473 mL in 1 BOTTLE (60575-313-16) |
NDC Code | 60575-313-16 |
Proprietary Name | Tricode |
Package Description | 473 mL in 1 BOTTLE (60575-313-16) |
Product NDC | 60575-313 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Chlorpheniramine Maleate, Codeine Phosphate, Pseudoephedrine Hydrochloride |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20110620 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Respa Pharmaceuticals, Inc. |
Substance Name | CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE |
Strength Number | 2; 8; 30 |
Strength Unit | mg/5mL; mg/5mL; mg/5mL |
Pharmaceutical Classes |